n-Propyl(2S)-1-(3-bromo-3a,4,6,6a-tetrahydropyrrolo[3,4-d]isoxazol-5-yl)-4-methyl-1-oxopentan-2-ylcarbamate

ID: ALA3629343

Chembl Id: CHEMBL3629343

PubChem CID: 122194225

Max Phase: Preclinical

Molecular Formula: C15H24BrN3O4

Molecular Weight: 390.28

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOC(=O)N[C@@H](CC(C)C)C(=O)N1CC2ON=C(Br)C2C1

Standard InChI:  InChI=1S/C15H24BrN3O4/c1-4-5-22-15(21)17-11(6-9(2)3)14(20)19-7-10-12(8-19)23-18-13(10)16/h9-12H,4-8H2,1-3H3,(H,17,21)/t10?,11-,12?/m0/s1

Standard InChI Key:  ZYVXXCMWSKMEGK-CXQJBGSLSA-N

Alternative Forms

  1. Parent:

    ALA3629343

    ---

Associated Targets(Human)

CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

rhodesain Rhodesain (1463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.28Molecular Weight (Monoisotopic): 389.0950AlogP: 2.10#Rotatable Bonds: 6
Polar Surface Area: 80.23Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.20CX Basic pKa: CX LogP: 2.09CX LogD: 2.09
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -0.53

References

1. Ettari R, Pinto A, Previti S, Tamborini L, Angelo IC, La Pietra V, Marinelli L, Novellino E, Schirmeister T, Zappalà M, Grasso S, De Micheli C, Conti P..  (2015)  Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.,  23  (21): [PMID:26432608] [10.1016/j.bmc.2015.09.029]

Source